Search
ISSN:
Website:
Publisher:
Disciplines
(Field of Science):
- biomedical engineering (Engineering and Technology)
- medical biology (Medical and Health Sciences )
- pharmacology and pharmacy (Medical and Health Sciences )
- medical sciences (Medical and Health Sciences )
- physical culture science (Medical and Health Sciences )
- health sciences (Medical and Health Sciences )
- food and nutrition technology (Agricultural sciences)
- biotechnology (Natural sciences)
- chemical sciences (Natural sciences)
(Field of Science)
Ministry points: Help
| Year | Points | List |
|---|---|---|
| Year 2024 | 100 | Ministry scored journals list 2024 |
| Year | Points | List |
|---|---|---|
| 2024 | 100 | Ministry scored journals list 2024 |
| 2023 | 140 | Ministry Scored Journals List |
| 2022 | 100 | Ministry Scored Journals List 2019-2022 |
| 2021 | 100 | Ministry Scored Journals List 2019-2022 |
| 2020 | 100 | Ministry Scored Journals List 2019-2022 |
| 2019 | 100 | Ministry Scored Journals List 2019-2022 |
| 2018 | 25 | A |
| 2017 | 25 | A |
| 2016 | 25 | A |
| 2015 | 25 | A |
| 2014 | 25 | A |
| 2013 | 25 | A |
| 2012 | 25 | A |
| 2011 | 25 | A |
| 2009 | 20 | List of scored magazines |
Model:
Points CiteScore:
| Year | Points |
|---|---|
| Year 2022 | 7.4 |
| Year | Points |
|---|---|
| 2022 | 7.4 |
| 2021 | 5.6 |
| 2020 | 5.1 |
| 2019 | 4.9 |
| 2018 | 5.3 |
| 2017 | 4.4 |
| 2016 | 4.3 |
| 2015 | 3.8 |
| 2014 | 3.5 |
| 2013 | 3.7 |
| 2012 | 4.1 |
| 2011 | 4.1 |
Impact Factor:
Sherpa Romeo:
Papers published in journal
Filters
total: 28
Catalog Journals
Year 2023
-
Gαi-derived peptide binds the µ-opioid receptor
Publication
Year 2020
-
Proof-of-concept study on improved efficacy of rHuEPO administered as a long-term infusion in rats
Publication -
Population pharmacokinetics of standard-dose meropenem in critically ill patients on continuous renal replacement therapy: a prospective observational trial
Publication
Year 2018
-
Modulation of UDP-glucuronidation by acridinone antitumor agents C-1305 and C-1311 in HepG2 and HT29 cell lines, despite slight impact in noncellular systems.
PublicationBackground Among the studied antitumor acridinone derivatives developed in our laboratory, 5-dimethylaminopropylamino-8-hydroxytriazoloacridinone (C-1305) and 5-diethylaminoethylamino-8-hydroxyimidazoacridinone (C-1311) exhibited cytotoxic and antitumor properties against several cancer types and were selected to be evaluated in preclinical and early-phase clinical trials. In the present work, we investigated the impact of C-1305...
-
Drug-drug interaction potential of antitumor acridine agent C-1748: The substrate of UDP-glucuronosyltransferases 2B7, 2B17 and the inhibitor of 1A9 and 2B7
PublicationBackground The compound 9-(2′-hydroxyethylamino)-4-methyl-1-nitroacridine (C-1748), the promising antitumor agent developed in our laboratory was determined to undergo phase I metabolic pathways. The present studies aimed to know its biotransformation with phase II enzymes – UDP-glucuronosyltransferases (UGTs) and its potential to be engaged in drug-drug interactions arising from the modulation of UGT activity. Methods UGT-mediated...
-
Comparison of the effects of rosuvastatin monotherapy and atorvastatin-ezetimibe combined therapy on the structure of erythrocyte membranes in patients with coronary artery disease
Publication
Year 2017
-
Temozolomide and sorafenib as programmed cell death inducers of human glioma cells
Publication -
High-dose testosterone enanthate supplementation boosts oxidative stress, but exerts little effect on the antioxidant barrier in sedentary adolescent male rat liver
Publication -
Effect of intensive lipid-lowering therapies on cholinesterase activity in patients with coronary artery disease
Publication
Year 2016
-
Imidazoacridinone antitumor agent C-1311 as a selective mechanism- based inactivator of human cytochrome P450 1A2 and 3A4 isoenzymes.
Publication5-Diethylaminoethylamino-8-hydroxyimidazoacridinone (C-1311), a promising antitumor agent that is also active against autoimmune diseases, was determined to be a selective inhibitor of the cytochrome P450 (CYP) 1A2 and 3A4 isoenzymes. Therefore, C-1311 might modulate the effectiveness of other drugs used in multidrug therapy. The present work aimed to identify the mechanism of the observed C-1311-mediated inactivation of CYP1A2...
Year 2015
-
The effect of interleukin-35 on the integrity, ICAM-1 expression and apoptosis of human aortic smooth muscle cells
Publication -
Mesoporous silica nanoflakes – Biocompatibility, cellular uptake and drug transport
Publication -
Detrimental effects of chemotherapeutics and other drugs on the endothelium: A call for endothelial toxicity profiling
Publication
Year 2014
-
The influence of the time of day on midazolam pharmacokinetics and pharmacodynamics in rabbits
Publication -
Pharmacokinetics and pharmacodynamics of propofol in children undergoing different types of surgeries
Publication -
Chronic treatment with zinc hydroaspartate induces anti-inflammatory and anti-ulcerogenic activity in rats
Publication -
Catalase activity in blood fractions of patients with sporadic ALS
Publication
Year 2013
-
Possible contribution of IGF-1 to depressive disorder
Publication -
Assessing circadian rhythms during prolonged midazolam infusion in the pediatric intensive care unit (PICU) children
Publication
Year 2012
seen 1319 times